Aslani, Iris .

HRN: 24-25-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
05/13/2024
05/20/2024
PO
1ml
QID
Oral Candidiasis
Waiting Final Action 

Indication:  Empiric Then Culture-directed    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: